1. Chen, Yueda, Ye, Botian, Wang, Chunyan, Qin, Jing, Shen, Zhenbin. 2022. PLOD3 contributes to HER-2 therapy resistance in gastric cancer through FoxO3/Survivin pathway. In Cell death discovery, 8, 321. doi:10.1038/s41420-022-01103-4. https://pubmed.ncbi.nlm.nih.gov/35835735/
2. Maddirevula, Sateesh, Alzahrani, Fatema, Al-Owain, Mohammed, Monies, Dorota, Alkuraya, Fowzan S. 2018. Autozygome and high throughput confirmation of disease genes candidacy. In Genetics in medicine : official journal of the American College of Medical Genetics, 21, 736-742. doi:10.1038/s41436-018-0138-x. https://pubmed.ncbi.nlm.nih.gov/30237576/
3. Ewans, Lisa Jean, Colley, Alison, Gaston-Massuet, Carles, Buckley, Michael, Roscioli, Tony. 2019. Pathogenic variants in PLOD3 result in a Stickler syndrome-like connective tissue disorder with vascular complications. In Journal of medical genetics, 56, 629-638. doi:10.1136/jmedgenet-2019-106019. https://pubmed.ncbi.nlm.nih.gov/31129566/
4. Deng, Xianyu, Pan, Yun, Yang, Muqing, Liu, Ying, Li, Jiyu. 2021. PLOD3 Is Associated with Immune Cell Infiltration and Genomic Instability in Colon Adenocarcinoma. In BioMed research international, 2021, 4714526. doi:10.1155/2021/4714526. https://pubmed.ncbi.nlm.nih.gov/34239923/
5. Wang, Biao, Xu, Lingyan, Ge, Yugang, Chen, Xiaofeng, Gu, Yanhong. . PLOD3 is Upregulated in Gastric Cancer and Correlated with Clinicopathologic Characteristics. In Clinical laboratory, 65, . doi:10.7754/Clin.Lab.2018.180541. https://pubmed.ncbi.nlm.nih.gov/30775879/
6. Meng, Yiming, Sun, Jing, Zhang, Guirong, Yu, Tao, Piao, Haozhe. 2022. Clinical Prognostic Value of the PLOD Gene Family in Lung Adenocarcinoma. In Frontiers in molecular biosciences, 8, 770729. doi:10.3389/fmolb.2021.770729. https://pubmed.ncbi.nlm.nih.gov/35265665/
智鼠故事 
